Click here to jump to the main content
National Drug Policy New Zealand Home.

National Drug Policy New Zealand

Print this   Email this

Publications

Gamma-Hydroxybutyric Acid and Related Substances (Fantasy): EACD Advice to the Minister

Date of publication: Dec 2001

This paper considers gamma-hydroxybutyric acid ('GHB') and three GHB-related substances:
  • 1,4-Butanediol ('1,4-B')
  • Gamma butyrolactone ('GBL')
  • Gamma-aminobutyric acid ('GABA').
Such substances are commonly called 'Fantasy' and all have related 'class' effects.

These substances are not controlled under the Misuse of Drugs Act 1975 (the Act). After considering the available evidence, the EACD recommends that these drugs should be classified in Part 1 of the Second Schedule of the Act (ie, B1).

Document availability

This publication is available in PDF format.

EACD advice on Gamma-Hydroxybutyric Acid and Related Substances (PDF, 234 KB)